5 year predictions for tavi as a therapy for aortic stenosis - europcr 2023
Published 1 year ago • 738 plays • Length 7:40Download video MP4
Download video MP3
Similar videos
-
56:18
the conundrum of antithrombotic therapy in atrial fibrillation patients undergoing tavi-europcr 2022
-
1:00:24
contemporary best clinical practice for tavi - europcr 2023
-
1:31:20
long-term valve performance for the next decade and beyond - europcr 2023
-
45:45
tavi lifetime management: tailoring treatment options to secure future possibilities - europcr 2023
-
7:47
latest on tavi in complex bicuspid lesions - europcr 2023
-
54:59
double jeopardy: coronary disease in patients undergoing tavi - europcr 2022
-
1:30:14
redo-tavi and patient pathway optimisation - europcr 2023
-
40:32
tavi for ar - addressing an unmet need with the jenavalve trilogy heart valve system - europcr 2022
-
13:53
define flair 5-year and reveal ifr: learnings on coronary physiology - europcr 2023
-
1:03:19
how should we treat low risk patients with aortic stenosis? - webinar
-
1:05:50
defining together the ideal tavi platform of the future - europcr 2023
-
55:58
introducing navitor: a new tavi solution - europcr 2021
-
1:30:00
the optimal first valve choice for all patients with aortic stenosis - pcr tokyo valves 2023
-
9:48
duravr thv: a valve designed for life - europcr 2022
-
59:20
treatment of aortic stenosis for today - important considerations for the future. pcr london valves
-
59:45
a patient with severe aortic stenosis - webinar on the road #5
-
7:46
europcr 2023 highlights: interventions for valvular disease
-
5:02
the revolutionary treatment for aortic stenosis (full guide!)
-
9:27
the implications of the latest evidence for tavi in daily practice - europcr 2019